Anavex Life Sciences EBITDA 2010-2024 | AVXL

Anavex Life Sciences ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Anavex Life Sciences Annual EBITDA
(Millions of US $)
2023 $-56
2022 $-51
2021 $-42
2020 $-31
2019 $-29
2018 $-19
2017 $-16
2016 $-16
2015 $-3
2014 $0
2013 $-2
2012 $-4
2011 $-6
2010 $-5
2009 $-5
Anavex Life Sciences Quarterly EBITDA
(Millions of US $)
2024-03-31 $-13
2023-12-31 $-11
2023-09-30 $-13
2023-06-30 $-14
2023-03-31 $-14
2022-12-31 $-15
2022-09-30 $-15
2022-06-30 $-12
2022-03-31 $-12
2021-12-31 $-12
2021-09-30 $-12
2021-06-30 $-11
2021-03-31 $-9
2020-12-31 $-9
2020-09-30 $-8
2020-06-30 $-8
2020-03-31 $-8
2019-12-31 $-8
2019-09-30 $-6
2019-06-30 $-7
2019-03-31 $-8
2018-12-31 $-7
2018-09-30 $-6
2018-06-30 $-5
2018-03-31 $-5
2017-12-31 $-4
2017-09-30 $-5
2017-06-30 $-4
2017-03-31 $-4
2016-12-31 $-3
2016-09-30 $-7
2016-06-30 $-2
2016-03-31 $-2
2015-12-31 $-5
2015-09-30 $-3
2015-06-30 $1
2015-03-31 $-0
2014-12-31 $-1
2014-09-30 $2
2014-06-30 $-1
2014-03-31 $-1
2013-12-31 $-0
2013-09-30 $-2
2013-06-30 $-0
2013-03-31 $-0
2012-12-31 $-0
2012-09-30 $-1
2012-06-30 $-1
2012-03-31 $-1
2011-12-31 $-2
2011-09-30 $-1
2011-06-30 $-2
2011-03-31 $-2
2010-12-31 $-1
2010-09-30 $-3
2010-06-30 $-0
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-2
2009-06-30 $-1
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.313B $0.000B
ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $161.306B 16.14
Vertex Pharmaceuticals (VRTX) United States $124.260B 31.97
Regeneron Pharmaceuticals (REGN) United States $111.347B 27.23
CSL (CSLLY) Australia $91.083B 0.00
Bristol Myers Squibb (BMY) United States $87.206B 40.97
GSK (GSK) United Kingdom $85.094B 10.16
Gilead Sciences (GILD) United States $80.843B 16.10
Moderna (MRNA) United States $56.869B 0.00
Biogen (BIIB) United States $32.867B 15.05
BioNTech SE (BNTX) Germany $23.487B 197.60
Argenex SE (ARGX) Netherlands $22.393B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.787B 0.00
Genmab (GMAB) Denmark $18.065B 21.18
Illumina (ILMN) United States $17.936B 127.94
BioMarin Pharmaceutical (BMRN) United States $15.925B 62.13
BeiGene (BGNE) Cayman Islands $15.177B 0.00
Incyte (INCY) United States $13.356B 20.65
Bio-Techne Corp (TECH) United States $12.117B 45.77
Sarepta Therapeutics (SRPT) United States $11.473B 1011.50
QIAGEN (QGEN) Netherlands $10.032B 21.43
Insmed (INSM) United States $9.194B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.227B 26.90
Legend Biotech (LEGN) United States $8.066B 0.00
Vaxcyte (PCVX) United States $7.896B 0.00
Repligen (RGEN) United States $7.861B 102.69
Roivant Sciences (ROIV) United Kingdom $7.808B 0.00
Exact Sciences (EXAS) United States $7.776B 0.00
Ascendis Pharma (ASND) Denmark $7.682B 0.00
Intra-Cellular Therapies (ITCI) United States $7.298B 0.00
Exelixis (EXEL) United States $6.680B 34.42
Blueprint Medicines (BPMC) United States $6.600B 0.00
Halozyme Therapeutics (HALO) United States $6.354B 17.64
Viking Therapeutics (VKTX) United States $5.814B 0.00
Cytokinetics (CYTK) United States $5.588B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.291B 0.00
Apellis Pharmaceuticals (APLS) United States $5.188B 0.00
Nuvalent (NUVL) United States $5.103B 0.00
Krystal Biotech (KRYS) United States $5.069B 0.00
Zealand Pharma (ZLDPF) Denmark $4.866B 0.00
Alkermes (ALKS) Ireland $4.195B 16.42
ImmunityBio (IBRX) United States $4.122B 0.00
Guardant Health (GH) United States $3.732B 0.00
Immunovant (IMVT) United States $3.666B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.442B 0.00
Axsome Therapeutics (AXSM) United States $3.376B 0.00
Merus (MRUS) Netherlands $3.352B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.121B 0.00
Amicus Therapeutics (FOLD) United States $3.080B 0.00
Denali Therapeutics (DNLI) United States $3.080B 0.00
Biohaven (BHVN) United States $3.020B 0.00
Geron (GERN) United States $3.019B 0.00
Twist Bioscience (TWST) United States $3.004B 0.00
Arcellx (ACLX) United States $2.889B 0.00
SpringWorks Therapeutics (SWTX) United States $2.883B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.865B 0.00
IDEAYA Biosciences (IDYA) United States $2.844B 0.00
MorphoSys AG (MOR) Germany $2.776B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.774B 0.00
Avidity Biosciences (RNA) United States $2.766B 0.00
Apogee Therapeutics (APGE) United States $2.526B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.483B 0.00
Certara (CERT) United States $2.458B 56.59
Rhythm Pharmaceuticals (RYTM) United States $2.446B 0.00
ADMA Biologics Inc (ADMA) United States $2.434B 95.46
Iovance Biotherapeutics (IOVA) United States $2.412B 0.00
Novavax (NVAX) United States $2.348B 0.00
CG Oncology (CGON) United States $2.346B 0.00
Celldex Therapeutics (CLDX) United States $2.344B 0.00
Structure Therapeutics (GPCR) United States $2.333B 0.00
Intellia Therapeutics (NTLA) United States $2.291B 0.00
Fortrea Holdings (FTRE) United States $2.260B 27.78
Deciphera Pharmaceuticals (DCPH) United States $2.213B 0.00
Janux Therapeutics (JANX) United States $2.180B 0.00
Kymera Therapeutics (KYMR) United States $2.121B 0.00
Vericel (VCEL) United States $2.105B 0.00
Vera Therapeutics (VERA) United States $2.102B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.080B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.055B 0.00
Beam Therapeutics (BEAM) United States $2.046B 0.00
Myriad Genetics (MYGN) United States $2.034B 0.00
Protagonist Therapeutics (PTGX) United States $1.991B 13.91
Zai Lab (ZLAB) China $1.988B 0.00
Bavarian Nordic (BVNRY) Denmark $1.931B 8.41
Arvinas (ARVN) United States $1.799B 0.00
Keros Therapeutics (KROS) United States $1.727B 0.00
Galapagos (GLPG) Belgium $1.727B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.686B 12.85
NeoGenomics (NEO) United States $1.681B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.642B 0.00
Kura Oncology (KURA) United States $1.637B 0.00
Akero Therapeutics (AKRO) United States $1.620B 0.00
Edgewise Therapeutics (EWTX) United States $1.597B 0.00
Dynavax Technologies (DVAX) United States $1.582B 201.50
Neumora Therapeutics (NMRA) United States $1.578B 0.00
Spyre Therapeutics (SYRE) United States $1.530B 0.00
Sana Biotechnology (SANA) United States $1.526B 0.00
Belite Bio (BLTE) United States $1.454B 0.00
Vir Biotechnology (VIR) United States $1.446B 0.00
Ligand Pharmaceuticals (LGND) United States $1.442B 23.56
Arcus Biosciences (RCUS) United States $1.423B 0.00
Morphic Holding (MORF) United States $1.413B 0.00
ANI Pharmaceuticals (ANIP) United States $1.362B 16.91
Cullinan Therapeutics (CGEM) United States $1.340B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.331B 0.00
MannKind (MNKD) United States $1.266B 155.00
Mirum Pharmaceuticals (MIRM) United States $1.235B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.232B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.147B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.142B 0.00
Immatics (IMTX) Germany $1.123B 0.00
Prothena (PRTA) Ireland $1.102B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.096B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.081B 0.00
Tyra Biosciences (TYRA) United States $1.062B 0.00
Liquidia Technologies (LQDA) United States $1.055B 0.00
MiMedx (MDXG) United States $1.030B 43.62
Bicycle Therapeutics (BCYC) United Kingdom $1.017B 0.00
AbCellera Biologics (ABCL) Canada $1.009B 0.00
Disc Medicine (IRON) United States $0.967B 0.00
CureVac (CVAC) Germany $0.951B 0.00
Immunome (IMNM) United States $0.942B 0.00
Gyre Therapeutics (GYRE) United States $0.923B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.901B 0.00
Prime Medicine (PRME) United States $0.891B 0.00
Abivax SA (ABVX) France $0.887B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.872B 0.00
Viridian Therapeutics (VRDN) United States $0.859B 0.00
89BIO (ETNB) United States $0.854B 0.00
Cogent Biosciences (COGT) United States $0.843B 0.00
Cytek Biosciences (CTKB) United States $0.835B 0.00
Humacyte (HUMA) United States $0.832B 0.00
Mesoblast (MESO) Australia $0.832B 0.00
Stoke Therapeutics (STOK) United States $0.826B 0.00
PureTech Health (PRTC) United States $0.807B 0.00
Nurix Therapeutics (NRIX) United States $0.794B 0.00
Scholar Rock Holding (SRRK) United States $0.774B 0.00
Olema Pharmaceuticals (OLMA) United States $0.762B 0.00
WAVE Life Sciences (WVE) Singapore $0.759B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.742B 0.00
Tango Therapeutics (TNGX) United States $0.739B 0.00
HilleVax (HLVX) United States $0.734B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.710B 0.00
Nuvation Bio (NUVB) United States $0.704B 0.00
Dianthus Therapeutics (DNTH) United States $0.703B 0.00
CARGO Therapeutics (CRGX) United States $0.686B 0.00
Pliant Therapeutics (PLRX) United States $0.681B 0.00
Zymeworks (ZYME) United States $0.679B 0.00
Praxis Precision Medicines (PRAX) United States $0.674B 0.00
REGENXBIO (RGNX) United States $0.669B 0.00
AnaptysBio (ANAB) United States $0.646B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.646B 0.00
Mineralys Therapeutics (MLYS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Aerovate Therapeutics (AVTE) United States $0.641B 0.00
ArriVent BioPharma (AVBP) United States $0.627B 0.00
GH Research (GHRS) Ireland $0.624B 0.00
Pharming Group (PHGUF) Netherlands $0.606B 0.00
Arbutus Biopharma (ABUS) United States $0.600B 0.00
Castle Biosciences (CSTL) United States $0.595B 0.00
ITeos Therapeutics (ITOS) United States $0.590B 0.00
PepGen (PEPG) United States $0.581B 0.00
Applied Therapeutics (APLT) United States $0.579B 0.00
Pharming Group (PHAR) Netherlands $0.575B 0.00
Third Harmonic Bio (THRD) United States $0.572B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Kyverna Therapeutics (KYTX) United States $0.564B 0.00
Replimune (REPL) United States $0.553B 0.00
Cartesian Therapeutics (RNAC) United States $0.547B 0.00
Northwest Biotherapeutics (NWBO) United States $0.545B 0.00
Oric Pharmaceuticals (ORIC) United States $0.540B 0.00
Travere Therapeutics (TVTX) United States $0.538B 0.00
Cabaletta Bio (CABA) United States $0.534B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.529B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.527B 0.00
Entrada Therapeutics (TRDA) United States $0.526B 24.71
Absci (ABSI) United States $0.510B 0.00
Adaptive Biotechnologies (ADPT) United States $0.508B 0.00
Avid Bioservices (CDMO) United States $0.507B 0.00
Annexon (ANNX) United States $0.505B 0.00
Astria Therapeutics (ATXS) United States $0.499B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.494B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.491B 0.00
MaxCyte (MXCT) United States $0.489B 0.00
Oculis Holding AG (OCS) Switzerland $0.483B 0.00
Neurogene (NGNE) United States $0.483B 0.00
ACELYRIN, INC (SLRN) United States $0.477B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.475B 0.00
Terns Pharmaceuticals (TERN) United States $0.474B 0.00
IGM Biosciences (IGMS) United States $0.474B 0.00
Voyager Therapeutics (VYGR) United States $0.472B 0.00
Fulcrum Therapeutics (FULC) United States $0.460B 0.00
Celcuity (CELC) United States $0.458B 0.00
TScan Therapeutics (TCRX) United States $0.450B 0.00
Editas Medicine (EDIT) United States $0.447B 0.00
ALX Oncology Holdings (ALXO) United States $0.446B 0.00
AC Immune (ACIU) Switzerland $0.443B 0.00
Fate Therapeutics (FATE) United States $0.443B 0.00
Allogene Therapeutics (ALLO) United States $0.436B 0.00
Alector (ALEC) United States $0.426B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.415B 0.00
Precigen (PGEN) United States $0.414B 0.00
Contineum Therapeutics (CTNM) United States $0.410B 0.00
Ocugen (OCGN) United States $0.392B 0.00
Erasca (ERAS) United States $0.390B 0.00
Anika Therapeutics (ANIK) United States $0.383B 323.25
EnGene Holdings (ENGN) United States $0.381B 0.00
Jasper Therapeutics (JSPR) United States $0.361B 0.00
Aura Biosciences (AURA) United States $0.354B 0.00
Agenus (AGEN) United States $0.352B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.349B 0.00
Emergent Biosolutions (EBS) United States $0.340B 0.00
C4 Therapeutics (CCCC) United States $0.334B 0.00
Nautilus Biotechnology (NAUT) United States $0.333B 0.00
Atea Pharmaceuticals (AVIR) United States $0.330B 0.00
Alto Neuroscience (ANRO) United States $0.326B 0.00
Nkarta (NKTX) United States $0.321B 0.00
Shattuck Labs (STTK) United States $0.320B 0.00
Amarin (AMRN) Ireland $0.316B 0.00
Sutro Biopharma (STRO) United States $0.312B 0.00
MeiraGTx Holdings (MGTX) United States $0.309B 0.00
Revance Therapeutics (RVNC) United States $0.307B 0.00
Urogen Pharma (URGN) United States $0.307B 0.00
Kamada (KMDA) Israel $0.293B 22.17
Inozyme Pharma (INZY) United States $0.292B 0.00
Tenaya Therapeutics (TNYA) United States $0.290B 0.00
Solid Biosciences (SLDB) United States $0.288B 0.00
Skye Bioscience (SKYE) United States $0.287B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.285B 0.00
XOMA (XOMA) United States $0.279B 0.00
CorMedix Inc (CRMD) United States $0.278B 0.00
Mersana Therapeutics (MRSN) United States $0.277B 0.00
Poseida Therapeutics (PSTX) United States $0.267B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.260B 0.00
GENFIT S.A (GNFT) France $0.258B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.257B 0.00
FibroBiologics (FBLG) United States $0.256B 0.00
UniQure (QURE) Netherlands $0.254B 0.00
Inovio Pharmaceuticals (INO) United States $0.252B 0.00
Scilex Holding (SCLX) United States $0.241B 0.00
Q32 Bio (QTTB) United States $0.238B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
Codexis (CDXS) United States $0.234B 0.00
ChromaDex (CDXC) United States $0.233B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
Ventyx Biosciences (VTYX) United States $0.226B 0.00
Candel Therapeutics (CADL) United States $0.225B 0.00
Ovid Therapeutics (OVID) United States $0.221B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.216B 0.00
Renovaro (RENB) United States $0.215B 0.00
Rezolute (RZLT) United States $0.214B 0.00
Innate Pharma S.A (IPHA) France $0.206B 0.00
Boundless Bio (BOLD) United States $0.205B 0.00
23andMe Holding (ME) United States $0.203B 0.00
Rani Therapeutics Holdings (RANI) United States $0.202B 0.00
2seventy Bio (TSVT) United States $0.202B 0.00
XBiotech (XBIT) United States $0.201B 0.00
Coherus BioSciences (CHRS) United States $0.198B 0.00
Invivyd (IVVD) United States $0.193B 0.00
Elevation Oncology (ELEV) United States $0.186B 0.00
Abeona Therapeutics (ABEO) United States $0.183B 0.00
Trevi Therapeutics (TRVI) United States $0.183B 0.00
Greenwich LifeSciences (GLSI) United States $0.183B 0.00
Molecular Partners AG (MOLN) Switzerland $0.181B 0.00
Oncobiologics (OTLK) United States $0.179B 0.00
X4 Pharmaceuticals (XFOR) United States $0.176B 0.00
Compugen (CGEN) Israel $0.176B 0.00
Caribou Biosciences (CRBU) United States $0.175B 0.00
Vigil Neuroscience (VIGL) United States $0.172B 0.00
Lifecore Biomedical (LFCR) United States $0.171B 0.00
Adocia (ADOCY) France $0.170B 0.00
INmune Bio (INMB) United States $0.168B 0.00
Compass Therapeutics (CMPX) United States $0.168B 0.00
Puma Biotechnology (PBYI) United States $0.167B 10.52
Zura Bio (ZURA) United States $0.167B 0.00
Inventiva S.A (IVA) France $0.166B 0.00
Repare Therapeutics (RPTX) Canada $0.161B 0.00
Biomea Fusion (BMEA) United States $0.159B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.159B 0.00
Alimera Sciences (ALIM) United States $0.152B 0.00
Adverum Biotechnologies (ADVM) United States $0.152B 0.00
Sagimet Biosciences (SGMT) United States $0.151B 0.00
I-Mab (IMAB) China $0.150B 0.00
G1 Therapeutics (GTHX) United States $0.150B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.149B 0.00
ScPharmaceuticals (SCPH) United States $0.148B 0.00
Kodiak Sciences (KOD) United States $0.148B 0.00
Opthea (OPT) Australia $0.146B 0.00
Semper Paratus Acquisition (TVGN) United States $0.145B 0.00
Syros Pharmaceuticals (SYRS) United States $0.140B 0.00
Werewolf Therapeutics (HOWL) United States $0.139B 0.00
TELA Bio (TELA) United States $0.138B 0.00
Cellectis S.A (CLLS) France $0.138B 0.00
ATyr Pharma (ATYR) United States $0.135B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.134B 0.00
Cardiff Oncology (CRDF) United States $0.132B 0.00
Adagene (ADAG) China $0.129B 0.00
Rapt Therapeutics (RAPT) United States $0.129B 0.00
Sangamo Therapeutics (SGMO) United States $0.126B 0.00
CervoMed (CRVO) United States $0.122B 0.00
Adlai Nortye (ANL) Cayman Islands $0.122B 0.00
Nuvectis Pharma (NVCT) United States $0.122B 0.00
Seres Therapeutics (MCRB) United States $0.120B 0.00
BioStem Technologies (BSEM) $0.120B 0.00
Omega Therapeutics (OMGA) United States $0.118B 0.00
Seer (SEER) United States $0.117B 0.00
Coya Therapeutics (COYA) United States $0.117B 0.00
CytomX Therapeutics (CTMX) United States $0.116B 7.45
Gossamer Bio (GOSS) United States $0.115B 0.00
Immunic (IMUX) United States $0.114B 0.00
Allakos (ALLK) United States $0.114B 0.00
Akoya Biosciences (AKYA) United States $0.108B 0.00
Bluebird Bio (BLUE) United States $0.108B 0.00
Adicet Bio (ACET) United States $0.106B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.102B 0.00
VistaGen Therapeutics (VTGN) United States $0.102B 0.00
PDS Biotechnology (PDSB) United States $0.101B 0.00
Connect Biopharma Holdings (CNTB) United States $0.101B 0.00
Affimed (AFMD) Germany $0.099B 0.00
DiaMedica Therapeutics (DMAC) United States $0.099B 0.00
BioHarvest Sciences (CNVCD) Canada $0.099B 0.00
Athira Pharma (ATHA) United States $0.098B 0.00
DBV Technologies S.A (DBVT) France $0.097B 0.00
Elutia (ELUT) United States $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
Eton Pharmaceuticals (ETON) United States $0.093B 90.50
BeyondSpring (BYSI) United States $0.092B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
Verastem (VSTM) United States $0.088B 0.00
Ikena Oncology (IKNA) United States $0.087B 0.00
IO Biotech (IOBT) Denmark $0.087B 0.00
Gritstone Bio (GRTS) United States $0.086B 0.00
Vor Biopharma (VOR) $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Elicio Therapeutics (ELTX) United States $0.083B 0.00
Precision BioSciences (DTIL) United States $0.083B 0.00
Cognition Therapeutics (CGTX) United States $0.083B 0.00
Galena Biopharma (SLS) United States $0.082B 0.00
Spero Therapeutics (SPRO) United States $0.080B 2.91
HOOKIPA Pharma (HOOK) United States $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
BioAtla (BCAB) United States $0.078B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.077B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.077B 0.00
Annovis Bio (ANVS) United States $0.076B 0.00
Entera Bio (ENTX) Israel $0.075B 0.00
Alpha Teknova (TKNO) United States $0.073B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.072B 0.00
Cue Biopharma (CUE) United States $0.072B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.071B 0.00
Instil Bio (TIL) United States $0.071B 0.00
Benitec Biopharma (BNTC) United States $0.070B 0.00
Aileron Therapeutics (ALRN) United States $0.070B 0.00
LakeShore Biopharma (LSB) China $0.070B 0.00
Checkpoint Therapeutics (CKPT) United States $0.070B 0.00
LENZ Therapeutics (LENZ) United States $0.069B 0.00
Kronos Bio (KRON) United States $0.069B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.069B 0.00
Intensity Therapeutics (INTS) United States $0.068B 0.00
Rallybio (RLYB) United States $0.068B 0.00
Atara Biotherapeutics (ATRA) United States $0.068B 0.00
Passage Bio (PASG) United States $0.067B 0.00
AVROBIO (AVRO) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.067B 0.00
Earth Science Tech (ETST) United States $0.067B 0.00
Genelux (GNLX) United States $0.066B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Dyadic (DYAI) United States $0.065B 0.00
China Health Industries Holdings (CHHE) China $0.065B 0.00
Celularity (CELU) United States $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.062B 0.00
Cidara Therapeutics (CDTX) United States $0.062B 0.00
IN8bio (INAB) United States $0.062B 0.00
Enzo Biochem (ENZ) United States $0.061B 0.00
Lantern Pharma (LTRN) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
AN2 Therapeutics (ANTX) United States $0.059B 0.00
Leap Therapeutics (LPTX) United States $0.058B 0.00
Bionano Genomics (BNGO) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.057B 0.00
CalciMedica (CALC) United States $0.056B 0.00
Ocean Biomedical (OCEA) United States $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.055B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.055B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
BioXcel Therapeutics (BTAI) United States $0.054B 0.00
Clene (CLNN) United States $0.053B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.052B 0.00
Kezar Life Sciences (KZR) United States $0.052B 0.00
Curis (CRIS) United States $0.051B 0.00
Immuneering (IMRX) United States $0.050B 0.00
ARCA Biopharma (ABIO) United States $0.048B 0.00
Dare Bioscience (DARE) United States $0.047B 0.00
Carmell (CTCX) United States $0.046B 0.00
Beyond Air (XAIR) United States $0.046B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Aadi Bioscience (AADI) United States $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
HCW Biologics (HCWB) United States $0.040B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.040B 0.00
NextCure (NXTC) United States $0.040B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
Eyenovia (EYEN) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Cara Therapeutics (CARA) United States $0.036B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
NKGen Biotech (NKGN) United States $0.035B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
Quince Therapeutics (QNCX) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
SAB Biotherapeutics (SABS) United States $0.031B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.028B 0.00
Cocrystal Pharma (COCP) United States $0.028B 0.00
UNITY Biotechnology (UBX) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.026B 0.00
Equillium (EQ) United States $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.025B 0.00
RenovoRx (RNXT) United States $0.025B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Aprea Therapeutics (APRE) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Vincerx Pharma (VINC) United States $0.022B 0.00
Forte Biosciences (FBRX) United States $0.021B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
Apollomics (APLM) United States $0.020B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Sensei Biotherapeutics (SNSE) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
KALA BIO (KALA) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aptose Biosciences (APTO) Canada $0.016B 0.00
Purple Biotech (PPBT) Israel $0.015B 0.00
Galecto (GLTO) Denmark $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Monopar Therapeutics (MNPR) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Organovo Holdings (ONVO) United States $0.014B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Vaccinex (VCNX) United States $0.011B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.011B 0.00
Chemomab Therapeutics (CMMB) Israel $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.011B 0.00
Kintara Therapeutics (KTRA) United States $0.011B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
AEterna Zentaris (AEZS) Canada $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
BioCardia (BCDA) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Telesis Bio (TBIO) United States $0.005B 0.00
Longeveron (LGVN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
ThermoGenesis Holdings (THMO) United States $0.004B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Soligenix (SNGX) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
TRACON Pharmaceuticals (TCON) United States $0.003B 0.31
Invo BioScience (INVO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Seelos Therapeutics (SEEL) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Mustang Bio (MBIO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
CNS Pharmaceuticals (CNSP) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00